Cargando…

Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study

OBJECTIVE: People with impaired glucose tolerance (IGT) have increased risk of mortality and a high risk of progression to diabetes, but the extent that the excess mortality is associated with IGT per se or is the result of subsequent diabetes is unclear. RESEARCH DESIGN AND METHODS: We compared mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Qiuhong, Zhang, Ping, Wang, Jinping, An, Yali, Gregg, Edward W., Li, Hui, Zhang, Bo, Shuai, Ying, Yang, Wenying, Chen, Yanyan, Liu, Shuqian, Engelgau, Michael M., Hu, Yinghua, Bennett, Peter H., Li, Guangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001147/
https://www.ncbi.nlm.nih.gov/pubmed/27411697
http://dx.doi.org/10.2337/dc16-0429
_version_ 1782450421039628288
author Gong, Qiuhong
Zhang, Ping
Wang, Jinping
An, Yali
Gregg, Edward W.
Li, Hui
Zhang, Bo
Shuai, Ying
Yang, Wenying
Chen, Yanyan
Liu, Shuqian
Engelgau, Michael M.
Hu, Yinghua
Bennett, Peter H.
Li, Guangwei
author_facet Gong, Qiuhong
Zhang, Ping
Wang, Jinping
An, Yali
Gregg, Edward W.
Li, Hui
Zhang, Bo
Shuai, Ying
Yang, Wenying
Chen, Yanyan
Liu, Shuqian
Engelgau, Michael M.
Hu, Yinghua
Bennett, Peter H.
Li, Guangwei
author_sort Gong, Qiuhong
collection PubMed
description OBJECTIVE: People with impaired glucose tolerance (IGT) have increased risk of mortality and a high risk of progression to diabetes, but the extent that the excess mortality is associated with IGT per se or is the result of subsequent diabetes is unclear. RESEARCH DESIGN AND METHODS: We compared mortality before and after the development of diabetes among 542 persons with IGT initially who participated in a 6-year lifestyle diabetes prevention trial and were followed-up from 1986 to 2009. RESULTS: During the 23-year follow-up, 174 (32.1%) died, with an overall death rate of 15.9/1,000 person-years. The majority of deaths (74.7%; 130 of 174) occurred after progression to type 2 diabetes, with age-adjusted death rates of 11.1/1,000 person-years (95% CI 8.2–12.0) before and 19.4/1,000 person-years (95% CI 11.9–23.3) after the development of type 2 diabetes. The cumulative mortality was 37.8% (95% CI 33.1–42.2%) in participants who developed type 2 diabetes during first 10 years of follow-up, 28.6% (95% CI 21.6–35.0%) in those who progressed to type 2 diabetes in 10–20 years, and 13.9% (95% CI 7.0–20.3%) in those who did not develop to type 2 diabetes within 20 years. Time-dependent multivariate Cox proportional hazards analyses, with adjustment for baseline age, sex, intervention, and other potential confounding risk factors, showed that the development of type 2 diabetes was associated with a 73% higher risk of death (hazard ratio 1.73 [95% CI 1.18–2.52]). CONCLUSIONS: As elsewhere, IGT is associated with increased risk of mortality in China, but much of this excess risk is attributable to the development of type 2 diabetes.
format Online
Article
Text
id pubmed-5001147
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-50011472017-09-01 Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study Gong, Qiuhong Zhang, Ping Wang, Jinping An, Yali Gregg, Edward W. Li, Hui Zhang, Bo Shuai, Ying Yang, Wenying Chen, Yanyan Liu, Shuqian Engelgau, Michael M. Hu, Yinghua Bennett, Peter H. Li, Guangwei Diabetes Care Epidemiology/Health Services Research OBJECTIVE: People with impaired glucose tolerance (IGT) have increased risk of mortality and a high risk of progression to diabetes, but the extent that the excess mortality is associated with IGT per se or is the result of subsequent diabetes is unclear. RESEARCH DESIGN AND METHODS: We compared mortality before and after the development of diabetes among 542 persons with IGT initially who participated in a 6-year lifestyle diabetes prevention trial and were followed-up from 1986 to 2009. RESULTS: During the 23-year follow-up, 174 (32.1%) died, with an overall death rate of 15.9/1,000 person-years. The majority of deaths (74.7%; 130 of 174) occurred after progression to type 2 diabetes, with age-adjusted death rates of 11.1/1,000 person-years (95% CI 8.2–12.0) before and 19.4/1,000 person-years (95% CI 11.9–23.3) after the development of type 2 diabetes. The cumulative mortality was 37.8% (95% CI 33.1–42.2%) in participants who developed type 2 diabetes during first 10 years of follow-up, 28.6% (95% CI 21.6–35.0%) in those who progressed to type 2 diabetes in 10–20 years, and 13.9% (95% CI 7.0–20.3%) in those who did not develop to type 2 diabetes within 20 years. Time-dependent multivariate Cox proportional hazards analyses, with adjustment for baseline age, sex, intervention, and other potential confounding risk factors, showed that the development of type 2 diabetes was associated with a 73% higher risk of death (hazard ratio 1.73 [95% CI 1.18–2.52]). CONCLUSIONS: As elsewhere, IGT is associated with increased risk of mortality in China, but much of this excess risk is attributable to the development of type 2 diabetes. American Diabetes Association 2016-09 2016-07-13 /pmc/articles/PMC5001147/ /pubmed/27411697 http://dx.doi.org/10.2337/dc16-0429 Text en © 2016 by the American Diabetes Association. http://diabetesjournals.org/site/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://diabetesjournals.org/site/license.
spellingShingle Epidemiology/Health Services Research
Gong, Qiuhong
Zhang, Ping
Wang, Jinping
An, Yali
Gregg, Edward W.
Li, Hui
Zhang, Bo
Shuai, Ying
Yang, Wenying
Chen, Yanyan
Liu, Shuqian
Engelgau, Michael M.
Hu, Yinghua
Bennett, Peter H.
Li, Guangwei
Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title_full Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title_fullStr Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title_full_unstemmed Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title_short Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study
title_sort changes in mortality in people with igt before and after the onset of diabetes during the 23-year follow-up of the da qing diabetes prevention study
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001147/
https://www.ncbi.nlm.nih.gov/pubmed/27411697
http://dx.doi.org/10.2337/dc16-0429
work_keys_str_mv AT gongqiuhong changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT zhangping changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT wangjinping changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT anyali changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT greggedwardw changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT lihui changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT zhangbo changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT shuaiying changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT yangwenying changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT chenyanyan changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT liushuqian changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT engelgaumichaelm changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT huyinghua changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT bennettpeterh changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy
AT liguangwei changesinmortalityinpeoplewithigtbeforeandaftertheonsetofdiabetesduringthe23yearfollowupofthedaqingdiabetespreventionstudy